Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Cash from Investing Activities (2022 - 2026)

Axsome Therapeutics' Cash from Investing Activities history spans 5 years, with the latest figure at -$121000.0 for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 64.2% to -$121000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$263000.0, a 48.43% increase, with the full-year FY2025 number at -$480000.0, down 77.78% from a year prior.
  • Cash from Investing Activities hit -$121000.0 in Q1 2026 for Axsome Therapeutics, down from -$71000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for AXSM hit a ceiling of -$7000.0 in Q4 2023 and a floor of -$53.2 million in Q2 2022.
  • Historically, Cash from Investing Activities has averaged -$3.2 million across 5 years, with a median of -$90000.0 in 2024.
  • The widest YoY moves for Cash from Investing Activities: up 99.75% in 2023, down 462.12% in 2023.
  • Tracing AXSM's Cash from Investing Activities over 5 years: stood at -$181000.0 in 2022, then skyrocketed by 96.13% to -$7000.0 in 2023, then crashed by 328.57% to -$30000.0 in 2024, then tumbled by 136.67% to -$71000.0 in 2025, then plummeted by 70.42% to -$121000.0 in 2026.
  • Business Quant data shows Cash from Investing Activities for AXSM at -$121000.0 in Q1 2026, -$71000.0 in Q4 2025, and -$58000.0 in Q3 2025.